"Tranquility and natural beauty. Academic and athletic opportunity. New York Tech's Long Island campus (Old Westbury, N.Y.) offers it all on Long Island’s historic North Shore. Named one of the nation’s safest campuses, our Long Island location is about an hour outside of New York City."

During the past decade, New York Institute of Technology conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "New York Institute of Technology" #1 collaborator was "National Institute on Aging (NIA)" with 1 trials as a collaborator and "New York Institute of Technology" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "New York Institute of Technology" are "Parkinson Disease" (4 trials), "Body Weight Changes" (2 trials), "Acidosis, Lactic" (1 trials), "Athletic Injuries" (1 trials) and "Autonomic Dysreflexia" (1 trials). Many other conditions were trialed in "New York Institute of Technology" in a lesser frequency.

Most popular intervention types in "New York Institute of Technology" are "Other" (9 trials), "Behavioral" (6 trials), "Device" (5 trials), "Dietary Supplement" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Osteopathic Manipulative Medicine" (2 trials), "Whole Body Periodic Acceleration" (2 trials), "ACE bandage" (1 trials), "Activity monitor" (1 trials) and "Aerobic exercise" (1 trials). Other intervention names were less common.

The vast majority of trials in "New York Institute of Technology" are 21 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "New York Institute of Technology". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in New York Institute of Technology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in New York Institute of Technology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 20 trials that are defined as “Not Applicable".